Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib

1. Verfasser:
In: Clinical and Translational Oncology, 16(2014), 11, S. 1012 - 1017
Format: E-Article
Sprache: Englisch
veröffentlicht: Springer Milan
Schlagworte:
ISSN: 1699-048X
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
finc.format ElectronicArticle
finc.mega_collection Springer Journals
finc.id dswarm-105-MTAuMTAwNy9zMTIwOTQtMDE0LTExODktMw
finc.record_id 10.1007/s12094-014-1189-3
finc.source_id 105
ris.type EJOUR
rft.atitle Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib
rft.eissn 1699-3055
rft.epage 1017
rft.genre article
rft.issn 1699-048X
rft.issue 11
rft.jtitle Clinical and Translational Oncology
rft.pages 1012-1017
rft.place Milan
rft.pub Springer Milan
rft.date 2014
x.date 2014-11-01T00:00:00Z
rft.stitle Clin Transl Oncol
rft.spage 1012
rft.volume 16
abstract Purpose<br/>TACE in combination with sorafenib might have acceptable safety and efficiency in the treatment of intermediate-advanced HCC.<br/>Methods<br/>TACE in combination with sorafenib might have acceptable safety and efficiency in the treatment of intermediate-advanced HCC.<br/>Results<br/>TACE in combination with sorafenib might have acceptable safety and efficiency in the treatment of intermediate-advanced HCC.<br/>Conclusions<br/>TACE in combination with sorafenib might have acceptable safety and efficiency in the treatment of intermediate-advanced HCC.<br/>
authors Zheng J.
doi 10.1007/s12094-014-1189-3
languages eng
url https://doi.org/10.1007/s12094-014-1189-3
x.subjects Hepatocellular carcinoma
Transcatheter arterial chemoembolization
Sorafenib treatment
Survival factors